"10.1371_journal.pone.0104178","plos one","2014-08-25T00:00:00Z","Steven A Safren; Katie B Biello; Laura Smeaton; Matthew J Mimiaga; Ann Walawander; Javier R Lama; Aadia Rana; Mulinda Nyirenda; Virginia M Kayoyo; Wadzanai Samaneka; Anjali Joglekar; David Celentano; Ana Martinez; Jocelyn E Remmert; Aspara Nair; Umesh G Lalloo; Nagalingeswaran Kumarasamy; James Hakim; Thomas B Campbell; for the PEARLS (ACTG A5175) Study Team","Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; The Fenway Institute, Fenway Health, Boston, MA, United States of America; Harvard School of Public Health, Boston, MA, United States of America; Frontier Science and Technology Research Foundation, Amherst, NY, United States of America; Asociacion Civil Impacta Salud y Educacion, Lima, Peru; Alpert Medical School/The Miriam Hospital, Providence, RI, United States of America; College of Medicine â€“ Johns Hopkins Research Project, Blantyre, Malawi; University of North Carolina Project, Lilongwe, Malawi; University of Zimbabwe-University of California San Francisco Collaborative Research Program, Harare, Zimbabwe; National AIDS Research Institute, Pune, India; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; NIH/NIAD/DAIDS Pharmaceutical Affairs, Bethesda, MD, United States of America; Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, S. Africa; YRGCARE Medical Centre, Chennai, India; University of Zimbabwe, Harare, Zimbabwe, Africa; University of Colorado Denver, Aurora, CO, United States of America","Conceived and designed the experiments: SAS LS AW DC AM AN NK JH TBC. Analyzed the data: SAS KBB LS MJM. Contributed to the writing of the manuscript: SAS KBB LS TBC. Manuscript review and approval: SAS KBB LS MJM AW JRL AR MN VMK WS AJ DC AM JER AN UGL NK JH TBC.","The authors of this manuscript have read the journals policy and have the following competing interests: the authors confirm that Javier Lama is on the PLOS ONE Editorial Board. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria. TBC received an honorarium from Gilead for serving on an advisory board. SAS, KBB, LS, MJM, AW, JRL, AR, MN, VMK, WS, AJ, DV, AM, JER, UGL, NK, and JH have no competing interests to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","08","Steven A Safren","SAS",20,FALSE,9,NA,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
